| Overview |
| bsm-90233r-50µL |
| Eph receptor B1 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Eph receptor B1 |
| 575-625/984 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 2047 |
| P54762 |
| EPHB1; EPH Receptor B1; EPHT2; HEK6; Neuronally-Expressed EPH-Related Tyrosine Kinase; Tyrosine-Protein Kinase Receptor EPH-2; Ephrin Type-B Receptor 1; EPH-Like Kinase 6; EC 2.7.10.1; Hek6; ELK; NET; EK6; Eph Tyrosine Kinase 2; EPH Tyrosine Kinase 2; EC 2.7.10; EphB1 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |